Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study
Open Access
- 1 September 2015
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 149 (3) , 586-595.e3
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Dabigatran Versus WarfarinStroke, 2013
- Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide studyBMJ Open, 2013
- Risk factors for gastrointestinal bleeding associated with low-dose aspirinBest Practice & Research Clinical Gastroenterology, 2012
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial FibrillationCirculation, 2011
- Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trialEuropean Heart Journal, 2011
- Dabigatran EtexilateCirculation, 2011
- Systematic review: the global incidence and prevalence of peptic ulcer diseaseAlimentary Pharmacology & Therapeutics, 2009
- Use of Health Care Databases in PharmacoepidemiologyBasic & Clinical Pharmacology & Toxicology, 2006
- The potential of UK clinical databases in enhancing paediatric medication researchBritish Journal of Clinical Pharmacology, 2005
- An estimate of chronic disease burden and some economic consequences among the elderly Hong Kong population.Journal of Epidemiology and Community Health, 1997